cyanates has been researched along with Neoplasms in 26 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (11.54) | 18.7374 |
| 1990's | 4 (15.38) | 18.2507 |
| 2000's | 5 (19.23) | 29.6817 |
| 2010's | 12 (46.15) | 24.3611 |
| 2020's | 2 (7.69) | 2.80 |
| Authors | Studies |
|---|---|
| Bowen, WD; Liu, CZ; McCurdy, CR; McVeigh, BM; Mottinelli, M; Nicholson, HE; Wong, NK | 1 |
| Ganguly, BB; Kadam, NN; Mandal, S | 1 |
| Comai, A; Ellison, GL; Hakkinen, PB; Harber, P; Holland, J; Lockey, JE; Pfahles-Hutchens, A; Redlich, CA; Streicher, R; Utell, M; White, M | 1 |
| Akhter, S; Ganesh, N; Malla, TM; Sah, NK; Senthilkumar, CS | 1 |
| Bhargava, A; Bunkar, N; Khare, NK; Mishra, PK; Raghuram, GV | 1 |
| Jatawa, SK; Khan, I; Sachdeva, M; Senthilkumar, CS; Singh, H; Tiwari, A; Upadhyay, N | 1 |
| Ganesh, N; Sah, NK; Senthilkumar, CS | 2 |
| Pigneux, A | 1 |
| Ganesh, N; Malla, TM; Sah, NK; Senthilkumar, CS | 1 |
| Senthilkumar, CS | 1 |
| Hagmar, L; Mikoczy, Z; Tinnerberg, H; Welinder, H | 1 |
| Crabb, C | 1 |
| Hagmar, L; Mikoczy, Z; Strömberg, U; Welinder, H | 1 |
| Hagmar, L; Mikoczy, Z; Welinder, H | 1 |
| Baur, X; Raulf-Heimsoth, M | 1 |
| Baur, X; Bolognesi, C; Marczynski, B; Norppa, H; Sabbioni, G; Sepai, O | 1 |
| Akbaş, H; Aydın, A; Karadağ, A; Şahin, O; Sen, F; Tekin, Ş | 1 |
| Encío, I; Palop, JA; Plano, D; Romano, B; Sanmartín, C | 1 |
| Baquedano, Y; Font, M; Jiménez-Ruiz, A; Moreno-Mateos, D; Palop, JA; Plano, D; Sanmartín, C | 1 |
| Guengerich, FP; Komori, M; Murayama, N; Shimada, T; Takenaka, S; Tanaka, K; Yamazaki, H | 1 |
| AMANTE, S; MANCINI, M | 1 |
| WIEL, P | 1 |
| Boros, LG; Cascante, M; Centelles, JJ; Comin-Anduix, B; de Atauri, P; Lee, PW | 1 |
7 review(s) available for cyanates and Neoplasms
| Article | Year |
|---|---|
Molecular bio-dosimetry for carcinogenic risk assessment in survivors of Bhopal gas tragedy.
Topics: Antisickling Agents; Bhopal Accidental Release; Carcinogens; Disasters; Humans; Incidence; India; Isocyanates; Neoplasms; Radiometry; Risk Assessment; Survival Rate; Survivors | 2015 |
Laromustine, a sulfonyl hydrolyzing alkylating prodrug for cancer therapy.
Topics: Aged; Animals; Antineoplastic Agents, Alkylating; Clinical Trials as Topic; Humans; Hydrazines; Isocyanates; Middle Aged; Neoplasms; Prodrugs; Sulfonamides | 2009 |
Methyl isocyanate and carcinogenesis: bridgeable gaps in scientific knowledge.
Topics: Animals; Breast Neoplasms; Carcinoma, Acinar Cell; Cell Transformation, Neoplastic; Female; Genomic Instability; Humans; Isocyanates; Lung Neoplasms; Male; Neoplasms; Pheochromocytoma; Rats | 2012 |
Pathomechanisms and pathophysiology of isocyanate-induced diseases--summary of present knowledge.
Topics: Alveolitis, Extrinsic Allergic; Animals; Asthma; Humans; Immunoglobulin E; Isocyanates; Neoplasms; Occupational Diseases | 1998 |
Toluene diisocyanates.
Topics: Animals; Carcinogenicity Tests; Carcinogens; Humans; Isocyanates; Mutagenicity Tests; Mutagens; Neoplasms; Neoplasms, Experimental; Occupational Exposure; Toluene | 1999 |
Carcinogenic risk of toluene diisocyanate and 4,4'-methylenediphenyl diisocyanate: epidemiological and experimental evidence.
Topics: Animals; Blood Proteins; Carcinogenicity Tests; Carcinogens; Chemical Industry; DNA Adducts; Female; Humans; Isocyanates; Male; Mutagenicity Tests; Neoplasms; Occupational Exposure; Protein Binding; Salmonella typhimurium; Toluene 2,4-Diisocyanate | 2001 |
Metabolic control analysis in drug discovery and disease.
Topics: Aneuploidy; Animals; Cell Division; Cyanates; Drug Industry; Genetics; Genotype; Humans; Neoplasms; Parasitic Diseases; Phenotype; Proteins; Rats | 2002 |
19 other study(ies) available for cyanates and Neoplasms
| Article | Year |
|---|---|
Identification and characterization of MAM03055A: A novel bivalent sigma-2 receptor/TMEM97 ligand with cytotoxic activity.
Topics: Antineoplastic Agents; Benzoxazoles; Cell Line, Tumor; Cell Survival; Drug Screening Assays, Antitumor; Humans; Isocyanates; Membrane Proteins; Neoplasms; Receptors, sigma | 2021 |
Spectrum of health condition in methyl isocyanate (MIC)-exposed survivors measured after 30 years of disaster.
Topics: Bhopal Accidental Release; Disasters; Environmental Exposure; Female; Health Status Indicators; Humans; Incidence; India; Isocyanates; Life Style; Male; Middle Aged; Morbidity; Neoplasms; Prevalence; Reproduction; Survivors | 2018 |
Isocyanates and human health: multistakeholder information needs and research priorities.
Topics: Biomarkers; Biomedical Research; Congresses as Topic; Consensus; Consumer Product Safety; Environmental Exposure; Environmental Monitoring; Health Priorities; Humans; Isocyanates; Models, Animal; Neoplasms; Occupational Diseases; Occupational Exposure; Occupational Health; Respiratory Tract Diseases | 2015 |
Increased micronucleus frequency in peripheral blood lymphocytes contributes to cancer risk in the methyl isocyanate-affected population of Bhopal.
Topics: Adolescent; Adult; Alcohol Drinking; Bhopal Accidental Release; Case-Control Studies; Cell Nucleus Division; Child; Environmental Exposure; Female; Humans; India; Isocyanates; Life Style; Lymphocytes; Male; Maternal Exposure; Micronuclei, Chromosome-Defective; Micronucleus Tests; Middle Aged; Neoplasms; Paternal Exposure; Pregnancy; Prenatal Exposure Delayed Effects; Risk Factors; Sex Factors; Smoking; Survivors; Tobacco, Smokeless; Young Adult | 2015 |
In silico docking of methyl isocyanate (MIC) and its hydrolytic product (1, 3-dimethylurea) shows significant interaction with DNA Methyltransferase 1 suggests cancer risk in Bhopal-Gas- Tragedy survivors.
Topics: Binding Sites; DNA (Cytosine-5-)-Methyltransferase 1; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; Environmental Exposure; Humans; India; Isocyanates; Methylurea Compounds; Molecular Docking Simulation; Neoplasms; Protein Binding; Protein Structure, Tertiary | 2015 |
On the long-term effects of methyl isocyanate on cell-mediated immunity in Bhopal gas-exposed long-term survivors and their offspring.
Topics: Adolescent; Adult; Bhopal Accidental Release; Biomarkers; Child; Female; Gas Poisoning; Humans; Immunity, Cellular; Immunosuppressive Agents; India; Inhalation Exposure; Isocyanates; Lymphocytosis; Male; Maternal Exposure; Middle Aged; Neoplasms; Paternal Exposure; Pesticides; Pulmonary Disease, Chronic Obstructive; Risk; Sex Factors; Survivors; Young Adult | 2017 |
Cancer morbidity among methyl isocyanate exposed long- term survivors and their offspring: a hospital-based five year descriptive study (2006 - 2011) and future directions to predict cancer risk in the affected population.
Topics: Adolescent; Adult; Aged; Antisickling Agents; Child; Child, Preschool; Family; Female; Follow-Up Studies; Humans; Incidence; Infant; Infant, Newborn; Isocyanates; Male; Middle Aged; Morbidity; Neoplasms; Prognosis; Survival Rate; Survivors; Young Adult | 2011 |
Bhopal methyl isocyanate affected population and cancer susceptibility: where do we stand now?
Topics: Antisickling Agents; Bhopal Accidental Release; Disease Susceptibility; Humans; India; Isocyanates; Neoplasms; Prognosis; Risk Factors | 2012 |
Cancer incidence and mortality of isocyanate exposed workers from the Swedish polyurethane foam industry: updated findings 1959-98.
Topics: Adult; Aged; Air Pollutants, Occupational; Chemical Industry; Cohort Studies; Female; Humans; Incidence; Isocyanates; Male; Middle Aged; Neoplasms; Occupational Diseases; Polyurethanes; Sex Distribution; Sweden | 2004 |
Revisiting the Bhopal tragedy.
Topics: Academies and Institutes; Accidents, Occupational; Antidotes; Biomedical Research; Chemical Industry; Cohort Studies; Disasters; Female; Gas Poisoning; Hospitals; Humans; India; Isocyanates; Male; Mutation; Neoplasms; Publishing; Pulmonary Surfactants; Thiosulfates | 2004 |
Incidence of cancer and exposure to toluene diisocyanate and methylene diphenyldiisocyanate: a cohort based case-referent study in the polyurethane foam manufacturing industry.
Topics: Case-Control Studies; Cohort Studies; Humans; Incidence; Isocyanates; Male; Neoplasms; Occupational Diseases; Occupational Exposure; Polyurethanes; Prostatic Neoplasms; Sweden; Toluene 2,4-Diisocyanate | 1993 |
Cancer incidence and mortality in the Swedish polyurethane foam manufacturing industry.
Topics: Adult; Aged; Cause of Death; Chemical Industry; Cohort Studies; Cyanates; Female; Humans; Incidence; Isocyanates; Male; Middle Aged; Neoplasms; Occupational Diseases; Occupational Exposure; Sweden; Time Factors; Toluene 2,4-Diisocyanate | 1993 |
Synthesis, characterization and anticancer activity in vitro evaluation of novel dicyanoaurate (I)-based complexes.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Movement; Cell Proliferation; Chlorocebus aethiops; Cyanates; Dose-Response Relationship, Drug; Gold; Humans; Inhibitory Concentration 50; Neoplasms; Solubility; Vero Cells | 2020 |
In vitro radical scavenging and cytotoxic activities of novel hybrid selenocarbamates.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cyanates; Free Radical Scavengers; Humans; Neoplasms; Organoselenium Compounds; Selenium Compounds | 2015 |
Selenocyanates and diselenides: a new class of potent antileishmanial agents.
Topics: Aminophenols; Animals; Antiprotozoal Agents; Cell Line, Tumor; Cyanates; Humans; Inhibitory Concentration 50; Leishmania infantum; Leishmaniasis, Visceral; Life Cycle Stages; Monocytes; Neoplasms; Phospholipid Ethers; Phosphorylcholine; Selenium Compounds; Structure-Activity Relationship | 2011 |
Spectral modification and catalytic inhibition of human cytochromes P450 1A1, 1A2, 1B1, 2A6, and 2A13 by four chemopreventive organoselenium compounds.
Topics: Animals; Antineoplastic Agents; Aryl Hydrocarbon Hydroxylases; Binding Sites; Biocatalysis; Catalytic Domain; Computer Simulation; Cyanates; Cytochrome P-450 CYP1A1; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP1A2 Inhibitors; Cytochrome P-450 CYP1B1; Cytochrome P-450 CYP2A6; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Humans; Neoplasms; Organoselenium Compounds; Protein Binding; Rats | 2011 |
[Study of thermocoagulation of the blood of the cancerous (Huggins test), with and without inhibition by potassium cyanate; control with various serum-function tests and with electrophoresis].
Topics: Blood Coagulation; Cyanates; Electrocoagulation; Electrophoresis; Neoplasms | 1954 |
[Diagnostic value and meaning of thermocoagulation (with potassium cyanate) of serum proteins in cancer and other diseases of the mouth].
Topics: Blood Proteins; Cyanates; Electrocoagulation; Humans; Mouth Diseases; Mouth Neoplasms; Neoplasms | 1955 |
[Round table discussion].
Topics: Cyanates; Humans; Neoplasms | 1957 |